| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 363,171 | 482,162 | 476,425 | 292,542 | | Cost of Revenue | 246,933 | 317,108 | 315,872 | 207,061 | | | Gross Profit | 116,238 | 165,054 | 160,553 | 85,481 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 96,312 | 113,484 | 103,397 | 88,147 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 19,926 | 51,570 | 57,156 | (2,666) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7 | 1,173 | 139 | (618) | | Earnings Before Interest And Taxes | 19,933 | 52,743 | 57,295 | (3,284) | | Interest Expense | 4,864 | 5,211 | 5,751 | 6,884 | | Income Before Tax | 15,069 | 47,532 | 51,544 | (10,168) | | Income Tax Expense | 6,870 | 15,371 | 17,980 | (3,853) | | Minority Interest | (163) | (1,085) | (544) | 131 | | | | Net Income From Continuing Ops | 8,036 | 31,076 | 33,020 | (6,184) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,036 | 31,076 | 33,020 | (6,184) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,036 | $31,076 | $33,020 | ($6,184) |
|
0.11% Nasdaq 
0.01%
Income Statement
